to manufacture and market Fingolimod Capsules, 0.5 mg. These capsules will be launched in the US market in March 2024. Fingolimod Capsules, 0.5 mg are prescribed to patients with relapsing forms of ...
Some results have been hidden because they may be inaccessible to you